Clinical Trial Update: Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating laboratory-treated central memory/naive CD8+ T cells for newly diagnosed or relapsed acute myeloid leukemia; the study status is te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Laboratory-Treated (Central Memory/Naive) CD8+ T Cells

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-06-23